Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Lens epithelium-derived growth factor (LEDGF)/p75 is the dominant binding partner of HIV-1 integrase (IN) in human cells. We have determined the NMR structure of the integrase-binding domain (IBD) in LEDGF and identified amino acid residues essential for the interaction. The IBD is a compact right-handed bundle composed of five alpha-helices. Based on folding topology, the IBD is structurally related to a diverse family of alpha-helical proteins that includes eukaryotic translation initiation factor eIF4G and karyopherin-beta. LEDGF residues essential for the interaction with IN were localized to interhelical loop regions of the bundle structure. Interaction-defective IN mutants were previously shown to cripple replication although they retained catalytic function. The initial structure determination of a host cell factor that tightly binds to a retroviral enzyme lays the groundwork for understanding enzyme-host interactions important for viral replication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The LEDGF/p75 IBD is an α-helical domain topologically related to HEAT repeat proteins108.”
From Structure and function of retroviral integrase (2022) · cites this paper as [108]
Citations
Cites
MOLMOL: A program for display and analysis of macromolecular structures
Koradi, R., Billeter, M., & Wüthrich, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00009-4 · Cited by 7,163
AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
X-PLOR Version 3.1: A System for X-ray Crystallography and NMR
Brünger, A. T. (1992) · Medical Entomology and Zoology · Cited by 3,424
Protein backbone angle restraints from searching a database for chemical shift and sequence homology
Cornilescu, G., Delaglio, F., & Bax, A. (1999) · Journal of Biomolecular NMR · doi:10.1023/a:1008392405740 · Cited by 2,957 · cited 1×
“Torsion angles p and ψ were predicted from 1 Hα, 13 Cα, 13 Cβ, C′ and backbone 15 N chemical shifts using TALO”
MethodAnatomy of hot spots in protein interfaces
Bogan, A. A., & Thorn, K. S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1843 · Cited by 1,988
HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells
Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., & Debyser, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209278200 · Cited by 704 · cited 1×
“dtd" [ ]> Transcriptional coactivator p75, more commonly known as LEDGF, is a chromatin-associated protei”
Self-citationComparison of ARM and HEAT protein repeats
Andrade, M. A., Petosa, C., O’Donoghue, S. I., Müller, C. W., & Bork, P. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4624 · Cited by 512
LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells
Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K., De Clercq, E., Debyser, Z., & Engelborghs, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303594200 · Cited by 493 · cited 2×
“The t(9;11)(p22;p15) chromosomal translocation associated with acute myeloid leukemia results in the fusion of the nucleoporin NUP98 to LEDGF5.”
BackgroundSelf-citationStructure of the nuclear transport complex karyopherin-β2–Ran˙GppNHp
Chook, Y. M., & Blobel, G. (1999) · Nature · doi:10.1038/20375 · Cited by 342
Cited by
Items 101–200 of 241
Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361–370
Hayouka, Z., Levin, A., Maes, M., Hadas, E., Shalev, D. E., Volsky, D. J., Loyter, A., & Friedler, A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.100 · Cited by 38
“This peptide, LEDGF 365–369 (for sequence, see Table 1), includes only the residues that are in close proximity to IN in the crystal structure, including residues I365 and D366 that are important for the interaction at the protein level [5,16] (Fig.”
BackgroundCellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery
Taltynov, O., Desimmie, B. A., Demeulemeester, J., Christ, F., & Debyser, Z. (2012) · Molecular Biology International · doi:10.1155/2012/863405 · Cited by 37
In search of small molecules blocking interactions between HIV proteins and intracellularcofactors
Busschots, K., Rijck, J. D., Christ, F., & Debyser, Z. (2008) · Molecular BioSystems · doi:10.1039/b810306b · Cited by 39
Virological and Cellular Roles of the Transcriptional Coactivator LEDGF/p75
Llano, M., Morrison, J. H., & Poeschla, E. M. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-02175-6_7 · Cited by 42
“As shown in Figure 3, the IBD is a compact structure comprised of a pair of alpha-helical hairpins [16].”
BackgroundIn Vitro DNA Tethering of HIV-1 Integrase by the Transcriptional Coactivator LEDGF/p75
McNeely, M., Hendrix, J., Busschots, K., Boons, E., Deleersnijder, A., Gérard, M., Christ, F., & Debyser, Z. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.073 · Cited by 39
Different Pathways Leading to Integrase Inhibitors Resistance
Thierry, E., Deprez, E., & Delelis, O. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02165 · Cited by 40
“…that displays a stable dimeric organization (Goldgur et al., 1998; Maignan et al., 1998; Chen et al., 2000; Laboulais et al., 2001; Wang et al., 2001; Cherepanov et al., 2005a; Hare et al., 2010a) encompassing the three highly conserved acids residues constituting the catalytic triad: Asp64,…”
BackgroundVanderlinden, W., Lipfert, J., Demeulemeester, J., Debyser, Z., & Feyter, S. D. (2014) · Nanoscale · doi:10.1039/c4nr00022f · Cited by 33
Feline Central Retinal Degeneration
Bellhorn, R. W., & Fischer, C. A. (1970) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1970.157.06.842 · Cited by 46
Sites of retroviral DNA integration: From basic research to clinical applications
Serrao, E., & Engelman, A. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1102859 · Cited by 36
“Single amino acid substitutions at either end of the tether, for example, the W21A change in the PWWP domain or the D366N change in the IBD, are sufficient to effectively break tethering function and render the mutant LEDGF/p75 protein unable to support HIV-1 integration (Botbol et al., 2008; Cherepanov et al., 2005;…”
BackgroundSelf-citationZhao, Y., Li, W., Zeng, J., Liu, G., & Tang, Y. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21955 · Cited by 29
Sapp, N., Burge, N. L., Cox, K. L., Thapa, S., Prakash, P., Balasubramaniam, M., Christensen, D. E., Li, M., Linderberger, J., Kvaratskhelia, M., et al. (2022) · Journal of Virology · doi:10.1128/jvi.01011-22 · Cited by 34
Interrogating HIV integrase for compounds that bind- a SAMPL challenge
Peat, T. S., Dolezal, O., Newman, J. M., Mobley, D. L., & Deadman, J. J. (2014) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9721-7 · Cited by 30
“The integrase protein forms a complex called the preintegration complex (PIC) with viral DNA and several cellular factors from the host [10] [14].”
BackgroundResistance to novel drug classes
Marcelin, A., Ceccherini‐Silberstein, F., Perno, C. F., & Cálvez, V. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328331d4b1 · Cited by 29
Strategies to inhibit viral protein nuclear import: HIV-1 as a target
Levin, A., Loyter, A., & Bukrinsky, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.07.010 · Cited by 34
“Based on the crystal structure and solution structure analysis of the complex between the LEDGF/p75 IBD and a dimer of the IN catalytic core domain it can be inferred that residues 361–370 of the IBD interact with the putative IN-NLS (residues 161–173) [18,21].”
BackgroundLocalization and functions of native and eGFP-tagged capsid proteins in HIV-1 particles
Francis, A. C., Cereseto, A., Singh, P. K., Shi, J., Poeschla, E. M., Engelman, A., Aiken, C., & Melikyan, G. B. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010754 · Cited by 22
Self-citationStructural Properties of HIV Integrase·Lens Epithelium-derived Growth Factor Oligomers
Gupta, K., Diamond, T., Hwang, Y., Bushman, F., & Van Duyne, G. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.114413 · Cited by 24
Vranckx, L. S., Demeulemeester, J., Debyser, Z., & Gijsbers, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164167 · Cited by 24
Xue, W., Liu, H., & Yao, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090799 · Cited by 24
The Interaction Between Lentiviral Integrase and LEDGF: Structural and Functional Insights
Hare, S., & Cherepanov, P. (2009) · Viruses · doi:10.3390/v1030780 · Cited by 28
“The solution structure of isolated LEDGFIBD was determined by NMR spectroscopy (PDB ID 1z9e), revealing a bundle of four long -helices (1, 2, 4, and 5) (Figure 3) [79].”
BackgroundMethodSelf-citationChromatin tethering and retroviral integration: Recent discoveries and parallels with DNA viruses
Meehan, A. M., & Poeschla, E. M. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.10.001 · Cited by 27
“The relatively small pocket at the LEDGF/p75-IN interface [12, 70] suggests a small molecule inhbitor is possible[145].”
BackgroundImpact of Chromatin on HIV Replication
Agosto, L. M., Gagné, M., & Henderson, A. J. (2015) · Genes · doi:10.3390/genes6040957 · Cited by 24
Tintori, C., Veljković, N., Veljković, V., & Botta, M. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22847 · Cited by 26
Ebina, H., Kanemura, Y., Suzuki, Y., Urata, K., Misawa, N., & Koyanagi, Y. (2012) · Virology · doi:10.1016/j.virol.2012.02.004 · Cited by 22
“, 2003) and recruits a pre-integration complex consisting of viral cDNA, host proteins and viral proteins to the gene coding region (Cherepanov et al., 2005; Engelman and Cherepanov, 2008; Shun et al., 2007).”
BackgroundInfluentialKilburg, D., & Gallicchio, E. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00022 · Cited by 23
“…most of the interaction energy of binding (Table 1, third column) at the expense of higher conformational strain (fifth column), resulting in a binding free energy 5 kcal/mol less favorable than wildtype in agreement with experimental evidence (Cherepanov et al., 2005b; Tsiang et al., 2009).”
BackgroundMethodResultInfluentialTsiang, M., Jones, G. S., Hung, M., Samuel, D., Novikov, N. Y., Mukund, S., Brendza, K. M., Niedziela‐Majka, A., Jin, D., Liu, X., et al. (2011) · Biochemistry · doi:10.1021/bi101504w · Cited by 22
Targeting Integration of the Saccharomyces Ty5 Retrotransposon
Brady, T., Schmidt, C. L., & Voytas, D. F. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-232-8_11 · Cited by 22
Vets, S., Kimpel, J., Volk, A., Rijck, J. D., Schrijvers, R., Verbinnen, B., Maes, W., von Laer, D., Debyser, Z., & Gijsbers, R. (2012) · Molecular Therapy · doi:10.1038/mt.2012.6 · Cited by 21
Zheng, Y., Ao, Z., Jayappa, K. D., & Yao, X. (2010) · Virology Journal · doi:10.1186/1743-422x-7-68 · Cited by 21
“highlighted the importance of E170A, H171A, LK172,3AA for LEDGF/p75 interaction [11,12,26].”
BackgroundInfluentialRetroviral integrase protein and intasome nucleoprotein complex structures
Grawenhoff, J., & Engelman, A. (2017) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v8.i1.32 · Cited by 26
Self-citationCrucitti, G. C., Pescatori, L., Messore, A., Madia, V. N., Pupo, G., Saccoliti, F., Scipione, L., Tortorella, S., Leva, F. S. D., Cosconati, S., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.06.036 · Cited by 19
Li, M., Chen, X., Wang, H., Jurado, K. A., Engelman, A. N., & Craigie, R. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.040 · Cited by 18
Self-citationAntiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles
Ajoge, H. O., Renner, T. M., Bélanger, K., Greig, M., Dankar, S. K., Kohio, H. P., Coleman, M. D., Ndashimye, E., Arts, E. J., Langlois, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35379-y · Cited by 23
HLA-associated production of anti-DFS70/LEDGF autoantibodies and systemic autoimmune disease
Muro, Y., Ogawa, Y., Sugiura, K., & Tomita, Y. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.03.005 · Cited by 18
Čermáková, K., Veverka, V., & Hodges, H. C. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220342 · Cited by 16
Targeted editing of the PSIP1 gene encoding LEDGF/p75 protects cells against HIV infection
Lampi, Y., Looveren, D. V., Vranckx, L. S., Thiry, I., Bornschein, S., Debyser, Z., & Gijsbers, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-38718-0 · Cited by 18
Retroviral integrase: Structure, mechanism, and inhibition
Passos, D. O., Li, M., Craigie, R., & Lyumkis, D. (2021) · The Enzymes · doi:10.1016/bs.enz.2021.06.007 · Cited by 22
“The structure of the IN-binding domain (IBD) of LEDGF in its free form [103] and bound to HIV-1 IN [104], provided insights into how the protein engages the integration complex.”
BackgroundGu, W.-G., Ip, D. T.-M., Liu, S.-J., Chan, J. H., Wang, Y., Zhang, X., Zheng, Y., & Wan, D. C. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.01.011 · Cited by 18
Su, K., Wang, D., Ye, J., Kim, Y. C., & Chow, S. A. (2009) · Methods · doi:10.1016/j.ymeth.2009.01.001 · Cited by 18
Blocking Nuclear Import of Pre-Integration Complex: An Emerging Anti-HIV-1 Drug Discovery Paradigm
Zhan, P., Liu, X., & Clercq, E. D. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416335 · Cited by 21
Cutiño‐Moguel, T., & Fassati, A. (2006) · Traffic · doi:10.1111/j.1600-0854.2006.00449.x · Cited by 20
“and directs PICs to highly transcribed chromatin regions susceptible to LEGDF/p75 regulation (19-21).”
De novo design of small molecule inhibitors targeting the LEDGF/p75-HIVintegrase interaction
Cavalluzzo, C., Voet, A. R. D., Christ, F., Singh, B. K., Sharma, A. K., Debyser, Z., Maeyer, M. D., & der Eycken, E. V. V. (2011) · RSC Advances · doi:10.1039/c1ra00582k · Cited by 19
Alaoui, N., Alaoui, M. A. E., Touil, N., Annaz, H. E., Melloul, M., Tagajdid, R., Hjira, N., Boui, M., Fahime, E. E., & Mrani, S. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3492-5 · Cited by 15
Mass spectrometry-based footprinting of protein–protein interactions
McKee, C. J., Kessl, J. J., Norris, J. O., Shkriabai, N., & Kvaratskhelia, M. (2008) · Methods · doi:10.1016/j.ymeth.2008.10.023 · Cited by 20
Optimized binding of substituted quinoline ALLINIs within the HIV-1 integrase oligomer
Sun, J., Patel, K., Hume, J. D., Pigza, J. A., Donahue, M. G., & Kessl, J. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100363 · Cited by 14
“LEDGF/p75 also binds the IN tetramer through its C-terminal integrase binding domain by inserting a small loop into a vshaped cavity located at the IN CCD dimer interface (10, 14).”
BackgroundIshihara, K., Fatma, N., Bhargavan, B., Chhunchha, B., Kubo, E., Dey, S., Takamura, Y., Kumar, A., & Singh, D. P. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08686.x · Cited by 16
Fragment hopping approach directed at design of HIV IN-LEDGF/p75 interaction inhibitors
Luca, L. D., Ferro, S., Morreale, F. E., Christ, F., Debyser, Z., Chimirri, A., & Gitto, R. (2012) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.703184 · Cited by 14
Zhang, X., Huang, S., Gu, W.-G., Yang, L., Chen, H., Zheng, C., Zhao, Y., Wan, D. C., & Zheng, Y. (2014) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(14)60031-5 · Cited by 16
Chromosomal tethering and proviral integration
Delelis, O., Zamborlini, A., Thierry, S., & Saïb, A. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.08.005 · Cited by 15
Vets, S., Rijck, J. D., Brendel, C., Grez, M., Bushman, F. D., Debyser, Z., & Gijsbers, R. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.4 · Cited by 13
Host Cell Factors and HIV-1 Integration
Engelman, A. (2007) · Future HIV Therapy · doi:10.2217/17469600.1.4.415 · Cited by 14
“Mutant proteins lacking the C-terminal IBD or carrying the Asp366→Asn substitution within the domain that abrogated the interaction with IN in vitro [59] and in yeast cells [60] also failed to support infection.”
BackgroundSelf-citationBennett, G. R., Peters, R., Wang, X., Hanne, J., Sobol, R. W., Bundschuh, R. A., Fishel, R. A., & Yoder, K. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103164 · Cited by 14
“The host protein LEDGF has been shown to directly bind the HIV integration complex and direct integration to sites within chromatin [46–48].”
1,2,3,4‐Tetrahydroisoquinolines as inhibitors of HIV ‐1 integrase and human LEDGF /p75 interaction
George, A., Reddy, A. G. K., Satyanarayana, G., & Raghavendra, N. K. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13175 · Cited by 13
HIV-1 integrase binding to genomic RNA 5′-UTR induces local structural changes in vitro and in virio
Liu, S., Koneru, P. C., Li, W., Pathirage, C., Engelman, A., Kvaratskhelia, M., & Musier‐Forsyth, K. (2021) · Retrovirology · doi:10.1186/s12977-021-00582-0 · Cited by 16
“Preparation of proteins and RNAs His6-tagged IN(F185H) and His6-tagged IBD (residues 307–460) [74, 75] were co-purified to form the IN (F185H)-IBD complex by using three chromatographic steps.”
MethodSelf-citationStructural Insights to Human Immunodeficiency Virus (HIV-1) Targets and Their Inhibition
Vanangamudi, M., Nair, P. C., Maida Engels, S. E., Senthilkumar, P., & Namasivayam, V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-0267-2_3 · Cited by 13
Borrenberghs, D., Zurnic, I., Wit, F. D., Acke, A., Dirix, L., Cereseto, A., Debyser, Z., & Hendrix, J. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1157 · Cited by 11
“In the LEDGF/p75 binding pocket of IN, a short interhelical loop of the IN binding domain (IBD) docks into a narrow V shaped cavity formed at the interface of a dimer of IN CCD molecules (65,69).”
BackgroundBradley, C. M., & Craigie, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509078102 · Cited by 14
Dinh, T., Tber, Z., Rey, J. S., Mengshetti, S., Annamalai, A. S., Haney, R., Briganti, L., Amblard, F., Fuchs, J. R., Cherepanov, P., et al. (2024) · mBio · doi:10.1128/mbio.00465-24 · Cited by 14
Self-citationVoet, A. R. D., Maeyer, M. D., Debyser, Z., & Christ, F. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.86 · Cited by 11
Wang, H., Shun, M.-C., Li, X., Nunzio, F. D., Hare, S., Cherepanov, P., & Engelman, A. (2014) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2013.2 · Cited by 12
Self-citationFerro, S., Luca, L. D., Morreale, F. E., Christ, F., Debyser, Z., Gitto, R., & Chimirri, A. (2013) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2013.766609 · Cited by 12
Biochemical and biophysical analyses of concerted (U5/U3) integration
Grandgenett, D. P., Bera, S., Pandey, K. K., Vora, A. C., Zahm, J. A., & Sinha, S. (2008) · Methods · doi:10.1016/j.ymeth.2008.11.002 · Cited by 11
Optimizing the Multimerization Properties of Quinoline-Based Allosteric HIV-1 Integrase Inhibitors
Sun, J., & Kessl, J. J. (2024) · Viruses · doi:10.3390/v16020200 · Cited by 12
“LEDGF/p75 interacts with the intasome through its Integrase Binding Domain (IBD) by inserting a small loop into a well-defined pocket located at the IN CCD dimer interface [14,17].”
BackgroundHIV-1 Integrase Inhibition: Looking at Cofactor Interactions
Christ, F., & Debyser, Z. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.162 · Cited by 10
Targeting Protein–Protein Interactions for HIV Therapeutics
Rice, A. P., & Sutton, R. E. (2007) · Future HIV Therapy · doi:10.2217/17469600.1.4.369 · Cited by 11
“The solution structure of the IBD of LEDGF is a compact right-handed, five α-helical bundle, topologically related to several other proteins [107].”
BackgroundGérard, A., Soler, N., Ségéral, E., Belshan, M., & Emiliani, S. (2013) · Retrovirology · doi:10.1186/1742-4690-10-13 · Cited by 12
“Structural studies revealed the roles of both the catalytic core domain dimeric interface and the N-terminal domain of IN for high affinity binding to IBD [60,66,67].”
BackgroundAn Unusual Helix Turn Helix Motif in the Catalytic Core of HIV-1 Integrase Binds Viral DNA and LEDGF
Merad, H., Porumb, H., Zargarian, L., René, B., Hobaika, Z., Maroun, R. G., Mauffret, O., & Fermandjian, S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004081 · Cited by 10
“In the complex, there are numerous stabilizing contacts, such as those involving the a3 helix and a portion of the a1 helix, but it is the turn region of HTHi ( residues Glu-170, His-171 and Gln-168 ) that makes the major contribution, particularly in binding the hotspot residue Asp-366 and the residue Ile-365 of LEDG…”
BackgroundMulti-Substituted Quinolines as HIV-1 Integrase Allosteric Inhibitors
Dinh, L. P., Sun, J., Glenn, C. D., Patel, K., Pigza, J. A., Donahue, M. G., Yet, L., & Kessl, J. J. (2022) · Viruses · doi:10.3390/v14071466 · Cited by 10
“The LEDGF/p75 interacts with the stable IN tetramer through its C-terminal integrase binding domain (IBD) by inserting a small loop into a v-shaped pocket located at the IN CCD dimer interface [12,15].”
BackgroundRole of LEDGF/p75 (PSIP1) in oncogenesis. Insights in molecular mechanism and therapeutic potential
Akele, M. Z., Iervolino, M., Belle, S. V., Christ, F., & Debyser, Z. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189248 · Cited by 8
Li, P., Tan, J., Liu, M., Zhang, X. Y., Chen, W. Z., & Wang, C. X. (2011) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2011.10507387 · Cited by 9
Bao, L., Hannon, C., Cruz-Migoni, A., Ptchelkine, D., Sun, M., Miller, A., Bunjobpol, W., Quevedo, C. E., Derveni, M., Chambers, J. S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16742-2 · Cited by 9
Protein-Protein Interactions as Drug Targets
Wendt, M. D. (2012) · Topics in Medicinal Chemistry · doi:10.1007/978-3-642-28965-1_1 · Cited by 9
Integrase anchors viral RNA to the HIV-1 capsid interior
Singer, M. R., Li, Z., Rey, J. S., Hope, J., Chenavier, F., Cook, N., Punch, E. K., Smith, J., Zhou, Z., Maslen, S., et al. (2026) · Nature · doi:10.1038/s41586-026-10154-x · Cited by 11
“To test this hypothesis, we produced viral particles by co-transfection of the HIV-Luc proviral construct with a vector expressing Vpr fused to WT or IN interaction-defective IBD mutant I365A/ D366N 37 ; a third construct with a stop codon to interrupt IBD translation was used as a control.”
Self-citationHeterogeneous elastic network model improves description of slow motions of proteins in solution
Li, M., Zhang, J. Z. H., & Xia, F. (2014) · Chemical Physics Letters · doi:10.1016/j.cplett.2014.11.006 · Cited by 8
HIV-1 Integrase Drug Discovery Comes of Age
Demeulemeester, J., Maeyer, M. D., & Debyser, Z. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_33 · Cited by 9
Xu, Z., Zheng, Y., Ao, Z., Clément, M., Mouland, A. J., Kalpana, G. V., Belhumeur, P., Cohen, É. A., & Yao, X. (2008) · Retrovirology · doi:10.1186/1742-4690-5-102 · Cited by 9
“It has also been shown that the V165A and L172A/K173A mutants were unable to bind LEDGF/p75 in vitro [9].”
BackgroundResultSchrijvers, R., Demeulemeester, J., Rijck, J. D., Christ, F., Gérard, M., Debyser, Z., & Gijsbers, R. (2012) · AIDS · doi:10.1097/qad.0b013e32835d0d86 · Cited by 7
“As a control we included LEDGF/p75 D366N, known to abrogate the interaction with HIV-1 integrase [12].”
BackgroundThys, W., Busschots, K., McNeely, M., Voet, A. R. D., Christ, F., & Debyser, Z. (2009) · HIV Therapy · doi:10.2217/17584310.3.2.171 · Cited by 6
Viral Protein Dimerization Quality Control: A Design Strategy for a Potential Viral Inhibitor
Du, S., Liu, X., Hu, X., & Zhan, P. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01540 · Cited by 5
Cornering HIV: Taking advantage of interactions between selective pressures
Ávila-Ríos, S., Reyes‐Terán, G., & Espinosa, E. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.12.012 · Cited by 6
Defining Pharmacological Targets by Analysis of Virus–Host Protein Interactions
Llano, M., & Peña-Hernández, M. A. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.11.001 · Cited by 7
“Asp366 in an interhelical loop of the host protein contacts, via hydrogen bonds, with residues Glu170 and His171 in one integrase monomer, whereas LEDGF/p75 residue Ile365 interacts with a hydrophobic pocket (Leu102, Ala128, Trp132) in the other integrase subunit (Cherepanov, Ambrosio, Rahman, Ellenberger, & Engelman,…”
Hannon, C., Cruz-Migoni, A., Platonova, O., Owen, R. L., Nettleship, J. E., Miller, A., Carr, S. B., Harris, G., Rabbitts, T. H., & Phillips, S. E. V. (2018) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x18001553 · Cited by 5
George, A., & Raghavendra, N. K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.035 · Cited by 4
Passaes, C., Cardoso, C. C., Caetano, D. G., Teixeira, S. L. M., Guimarães, M. L., Campos, D. P., Veloso, V. G., Babič, D. Z., Stevenson, M., Moraes, M. O., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101780 · Cited by 5
“This change affects, but not abolish the interaction with IN [52].”
BackgroundValidation of host factors of HIV integration as novel drug targets for anti-HIV therapy
Debyser, Z., Desimmie, B. A., Taltynov, O., Demeulemeester, J., & Christ, F. (2014) · MedChemComm · doi:10.1039/c3md00302g · Cited by 4
Dayer, M. R. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.29773 · Cited by 4
“Even though the full-length crystal structure of integrase from prototype foamy virus (PFV) in complex with DNA is available to model HIV-1 integrase in bioinformatics methods for drug design, there is an essential need for the full-length coordinate structure of HIV-1 integrase (29-39).”
BackgroundCellular Cofactors of HIV Integration
Thys, W., Bartholomeeusen, K., Debyser, Z., & Rijck, J. D. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch9 · Cited by 4
The role of chromatin in retroviral preintegration complex function
Sapp, N., Prakash, P., Chakraborty, R., Balasubramaniam, M., & Dash, C. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110440 · Cited by 3
Suryawanshi, G. W., Arokium, H., Kim, S., Khamaikawin, W., Lin, S., Shimizu, S., Chupradit, K., Lee, Y., Xie, Y., Guan, X., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02601-5 · Cited by 3
Benyamini, H., Loyter, A., & Friedler, A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.116 · Cited by 4
“For IN, we used the structure of the IN dimer in complex with LEDGF [32], since Rev was shown to bind tighter to LEDGF-bound IN than to free IN [1].”
MethodKumar, R., Sharma, M. C., Shaikh, N., & Garg, P. (2014) · Molecular Simulation · doi:10.1080/08927022.2014.935374 · Cited by 3
“[15–18] The NMR structure of LEDGF/p75 IBD has been reported (PDB: 1Z9E) and composed of compact bundle of five right-handed alpha helices.[19] The binding site and important interacting residues have been characterised.”
BackgroundInfluentialInteractions of HIV-1 Proteins as Targets for Developing Anti-HIV-1 Peptides
Chandra, K., Maes, M., & Friedler, A. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.46 · Cited by 3
Synthesis of Hexahydroquinoline-3-carboxamide Derivatives and Their HIV-1 Antiviral Activity
Bode, M. L., Coyanis, E. M., Mohlala, R. L., & Fish, M. Q. (2022) · Heterocycles · doi:10.3987/com-21-14602 · Cited by 2
Molecular Crosstalk between HIV-1 Integration and Host Proteins – Implications for Therapeutics
Suzuki, Y., Suzuki, Y., & Yamamoto, N. (2011) · InTech eBooks · doi:10.5772/23095 · Cited by 2
Ribone, S. R., & Quevedo, M. A. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.05.019 · Cited by 2
Protein-Protein Interaction Targets to Inhibit HIV-1 Infection
Kadow, J. F., Langley, D. R., Meanwell, N. A., Pracitto, R., Walker, M. A., & Yeung, K. (2012) · Topics in medicinal chemistry · doi:10.1007/978-3-642-28965-1_4 · Cited by 2
Retroviral Integration Target Site Selection
Ciuffi, A., & Bushman, F. D. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch5 · Cited by 2
Mechanistic and pharmacological analyses of HIV-1 integration
Engelman, A. (2009) · Methods · doi:10.1016/j.ymeth.2009.03.018 · Cited by 2
Self-citationTada, T., Kadoki, M., Liu, Y., Tokunaga, K., & Iwakura, Y. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00377 · Cited by 1
“…four functional domains, the N-terminal Pro-Trp-Trp-Pro domain (residues 1–93), the C-terminal IN-binding domain (residues 347–429), the nuclear localization signal and the AT-hook DNAbinding motif (Maertens et al., 2003; Cherepanov et al., 2004, 2005; Vanegas et al., 2005; Llano et al., 2006a,b).”
BackgroundBiochemical functions of integrase-binding domain of lens epithelium-derived growth factor
Kim, J., Hamid, F. B., & Shin, C. (2015) · Animal Cells and Systems · doi:10.1080/19768354.2015.1008040 · Cited by 1
“The lack of IBD failed to interact with HIV-1 IN (Cherepanov et al. 2004, 2005).”
BackgroundInterplay of HIV Integrase with Host Factors
Masuda, T. (2008) · The Journal of AIDS Research · doi:10.11391/aidsr1999.10.3 · Cited by 1
Metadata
- Authors
- Cherepanov, P., Sun, Z.-Y. J., Rahman, S., Maertens, G., Wagner, G., & Engelman, A.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Harvard University (US)
- Corresponding author
- Engelman, Alan
- Venue
- Nature Structural & Molecular Biology
- Published
- 2005-05-15
- Volume
- 12
- Issue
- 6
- Pages
- 526-532
- ISSN
- 1545-9985 (ISSN-L)
- 1545-9993
- OpenAlex
- W2083292764
- Cited by
- 235
- References
- 53
- Citations by year
- 2026: 7 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 7 · 2021: 10 · 2020: 5 · 2019: 2 · 2018: 8 · 2017: 6 · 2016: 9 · 2015: 13 · 2014: 24 · 2013: 13 · 2012: 17
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Structural & Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (GM47467, P01GM047467)
- National Institute of Allergy and Infectious Diseases (AI62249, R21AI062249, AI39394, AI 37581)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- LEDGF/p75, HIV-1 integrase, protein-protein interaction, alpha-helical bundle, interhelical loops, eIF4G, karyopherin beta, host-virus interaction, viral replication, NMR solution structure
- MeSH terms
- Amino Acid Sequence, Animals, Binding Sites, Cloning, Molecular, Fibroblast Growth Factors, Growth Substances, Humans, Mammals, Models, Molecular, Molecular Sequence Data, Magnetic Resonance Spectroscopy, Recombinant Proteins, Restriction Mapping, HIV-1, Mutagenesis, Open Reading Frames, Protein Structure, Secondary, HIV Integrase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.